Nathan W. Cummins

2.0k citations

63 papers · 1.3k indexed · h-index 22

Co-authors: Andrew D. Badley Sekar Natesampillai Gary D. Bren Scott H. Kaufmann Stacey A. Rizza Raymund R. Razonable Roshini S. Abraham Paul J. Deziel
Topics: HIV Research and Treatment (34 papers)HIV/AIDS drug development and treatment (18 papers)Immune Cell Function and Interaction (18 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: Journal of Biological ChemistrySHILAP Revista de lepidopterologíaThe Journal of Cell Biology
Partner nations: United States United Kingdom Australia

In The Last Decade

Nathan W. Cummins

59 papers receiving 1.3k citations

Peers

Countries citing papers authored by Nathan W. Cummins

Since Specialization

Citations

This map shows the geographic impact of Nathan W. Cummins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan W. Cummins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan W. Cummins more than expected).

Fields of papers citing papers by Nathan W. Cummins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan W. Cummins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan W. Cummins. The network helps show where Nathan W. Cummins may publish in the future.

Co-authorship network of co-authors of Nathan W. Cummins

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan W. Cummins. A scholar is included among the top collaborators of Nathan W. Cummins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan W. Cummins. Nathan W. Cummins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heart Transplantation from COVID-19–Positive Donors: A Word of Caution 2023 ·Transplantation Proceedings ·(unknown),(unknown),(unknown),(unknown),Philip J. Spencer,Richard C. Daly,(unknown),(unknown),Joseph J. Maleszewski,Mauricio A. Villavicencio,Nathan W. Cummins	2
2	Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort study 2021 ·BMJ Open ·Molly M. Jeffery,Nathan W. Cummins,Timothy Dempsey,Andrew H. Limper,Nilay D. Shah,Fernanda Bellolio	6
3	Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells 2020 ·Clinical Cancer Research ·(unknown),(unknown),Rondell P. Graham,Nathan W. Cummins,(unknown),Enrique Garcia-Rivera,J. Anderson,Sekar Natesampillai,(unknown),(unknown),Zilin Nie,Thomas D.Y. Chung,Richard Buick,Andrew L. Feldman,Rebecca L. King,Anne J. Novak,Stephen M. Ansell,Saad S. Kenderian,Andrew D. Badley	5
4	COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine 2020 ·Mayo Clinic Proceedings ·Naveen L. Pereira,Ferhaan Ahmad,Mirnela Byku,Nathan W. Cummins,Alanna A. Morris,Anjali Owens,Sony Tuteja,Sharon Cresci	54
5	Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2 2020 ·PLoS Pathogens ·(unknown),Sekar Natesampillai,(unknown),Cristina Correia,Kevin Peterson,(unknown),(unknown),(unknown),Ying Li,Scott H. Kaufmann,Andrew D. Badley,Nathan W. Cummins	29
6	Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death 2019 ·AIDS Research and Human Retroviruses ·(unknown),Andrew D. Badley,Nathan W. Cummins	15
7	Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection 2019 ·Biology of Blood and Marrow Transplantation ·Shukaib Arslan,Mark R. Litzow,Nathan W. Cummins,Stacey A. Rizza,Andrew D. Badley,Willis H. Navarro,Shahrukh K. Hashmi	10
8	Epidemiologic Factors, Clinical Presentation, Causes, and Outcomes of Liver Abscess: A 35-Year Olmsted County Study 2018 ·SHILAP Revista de lepidopterología ·Ayush Sharma,Saurabh Mukewar,Kristin C. Mara,Ross Dierkhising,Patrick S. Kamath,Nathan W. Cummins	23
9	An advanced BLT-humanized mouse model for extended HIV-1 cure studies 2017 ·AIDS ·Kerry J. Lavender,Craig S. Pace,Kathrin Sutter,Ronald J. Messer,(unknown),Nathan W. Cummins,Sekar Natesampillai,Jim Zheng,Joshua Goldsmith,Marek Widera,Erik Van Dis,Katie Phillips,Brent Race,Ulf Dittmer,George Kukolj,Kim J. Hasenkrug	54
10	Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells 2017 ·PLoS ONE ·Rahul Sampath,Nathan W. Cummins,Sekar Natesampillai,Gary D. Bren,Thomas D.Y. Chung,Jason V. Baker,Keith Henry,Amélie Pagliuzza,Andrew D. Badley	3
11	Protein tyrosine phosphatase 1B negatively regulates S100A9-mediated lung damage during respiratory syncytial virus exacerbations 2016 ·Mucosal Immunology ·Robert Foronjy,(unknown),Matthias Salathé,Abdoulaye Dabo,Edward Eden,Nathalie Baumlin,Nathan W. Cummins,Sailen Barik,Michael Campos,Edward B. Thorp,Patrick Geraghty	23
12	Twenty years of human immunodeficiency virus care at the Mayo Clinic: Past, present and future 2016 ·World Journal of Virology ·Nathan W. Cummins,Andrew D. Badley,Mary J. Kasten,Rahul Sampath,Zelalem Temesgen,Jennifer A. Whitaker,John Wilson,Joseph D. Yao,John D. Zeuli,Stacey A. Rizza	3
13	Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors 2014 ·Mucosal Immunology ·Robert Foronjy,Clifford C. Taggart,Abdoulaye Dabo,Sinéad Weldon,Nathan W. Cummins,Patrick Geraghty	31
14	HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation 2013 ·Journal of the American Heart Association ·Jason V. Baker,Kathleen E. Brummel‐Ziedins,Jacqueline Neuhaus,Daniel Duprez,Nathan W. Cummins,David Dalmau,Jack DeHovitz,Clara Lehmann,Ann Sullivan,Ian Woolley,Lewis H. Kuller,James D. Neaton,Russell P. Tracy,(unknown)	59
15	Short Communication: CD4 T Cell Declines Occurring During Suppressive Antiretroviral Therapy Reflect Continued Production of Casp8p41 2013 ·AIDS Research and Human Retroviruses ·Nathan W. Cummins,Jacqueline Neuhaus,(unknown),Michael Strausbauch,Peter J. Wettstein,Sharon R. Lewin,Montserrat Plana,Stacey A. Rizza,Zelalem Temesgen,Giota Touloumi,Matthew S. Freiberg,James D. Neaton,Andrew D. Badley,(unknown)	10
16	Isolation of a TRAIL Antagonist from the Serum of HIV-infected Patients 2011 ·Journal of Biological Chemistry ·(unknown),Brett D. Shepard,Gary D. Bren,Nathan W. Cummins,Sekar Natesampillai,Sergey Trushin,Alicia Algeciras-Schimnich,(unknown),(unknown),Stacey A. Rizza,Scott H. Kaufmann,Andrew D. Badley	13
17	Casp8p41 expression in primary T cells induces a proinflammatory response 2010 ·AIDS ·Julie Taylor,Nathan W. Cummins,Gary D. Bren,Stacey A. Rizza,Christopher P. Kolbert,Marshall D. Behrens,Keith L. Knutson,Jane Kahl,Yan W. Asmann,Andrew D. Badley	5
18	Intracellular Casp8p41 Content Is Inversely Associated with CD4 T Cell Count 2010 ·The Journal of Infectious Diseases ·Nathan W. Cummins,Wei Jiang,John W. McGinty,Gary D. Bren,Ronald J. Bosch,Alan Landay,Steven G. Deeks,Jeffrey N. Martin,Daniel C. Douek,Michael M. Lederman,Jason M. Brenchley,Andrew D. Badley	12
19	The TRAIL to Viral Pathogenesis: The Good, the Bad and the Ugly 2009 ·Current Molecular Medicine ·Nathan W. Cummins,Andrew D. Badley	46
20	Infected Cell Killing by HIV-1 Protease Promotes NF-κB Dependent HIV-1 Replication 2008 ·PLoS ONE ·Gary D. Bren,(unknown),Nathan W. Cummins,Brett D. Shepard,Stacey A. Rizza,Sergey A. Trushin,Andrew D. Badley	24

About Nathan W. Cummins

Nathan W. Cummins is a scholar working on Virology, Infectious Diseases and Immunology, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (34 papers), HIV/AIDS drug development and treatment (18 papers) and Immune Cell Function and Interaction (18 papers). The work is most often cited by research in Virology (589 citations), Infectious Diseases (564 citations) and Immunology (442 citations). Nathan W. Cummins has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Andrew D. Badley, Sekar Natesampillai, Gary D. Bren, Scott H. Kaufmann, Stacey A. Rizza, Raymund R. Razonable, Roshini S. Abraham, Paul J. Deziel, Cristina Correia and Rahul Sampath. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact